ctrl K

Watchlist Price Alert

Vaxcyte Inc. (PCVX)

NASDAQ: PCVX · Real-Time Price · USD

34.65

-0.37 (-1.06%)

At close: Jun 03, 2025, 3:59 PM

34.64

-0.03%

After-hours: Jun 03, 2025, 06:17 PM EDT

Vaxcyte Revenue Breakdown

Period Ending	Dec 31, 2021	Dec 31, 2020
Pneumococcal Conjugate Vaccine Revenue	7B	7B
Pneumococcal Conjugate Vaccine Revenue Growth	0.00%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	32.66M	28.55M	22.99M	18M	19.89M	14.58M	15.61M	14.46M	13.11M	11.95M	10.9M	9.42M	7.54M	6.77M	6.52M	6.08M	5.88M	4.79M	4.9M	3.05M	3.28M	2.46M	2.51M	2.26M	1.32M
Selling, General, and Administrative Revenue Growth	+14.37%	+24.22%	+27.74%	-9.50%	+36.40%	-6.58%	+7.95%	+10.25%	+9.71%	+9.67%	+15.73%	+24.84%	+11.39%	+3.82%	+7.30%	+3.30%	+22.81%	-2.16%	+60.80%	-7.16%	+33.54%	-2.11%	+10.87%	+72.04%	n/a
Research and Development Revenue	148.13M	133.61M	116.94M	131.51M	94.59M	104.15M	97.42M	72.69M	58.08M	51.63M	47.68M	38.47M	31.68M	23.07M	20.43M	17.65M	17.26M	14.66M	16.41M	18.18M	24.32M	13.38M	9.63M	9.97M	12.63M
Research and Development Revenue Growth	+10.87%	+14.26%	-11.08%	+39.03%	-9.18%	+6.91%	+34.02%	+25.16%	+12.50%	+8.28%	+23.94%	+21.44%	+37.29%	+12.95%	+15.73%	+2.28%	+17.71%	-10.66%	-9.73%	-25.24%	+81.70%	+38.96%	-3.39%	-21.06%	n/a